Logo of Huzzle

Home

Matches

Explore

Manage

Protein Engineer Intern

image

Bio-Techne

Feb 12, 2024

Applications are closed

  • Internship
    Full-time
    Summer Internship
  • Science
  • Minneapolis

Requirements

  • Must be a currently enrolled student pursuing a Bachelor's degree in a field relevant to the internship
  • Must have completed (at minimum) the sophomore year of college
  • Must have a current GPA of 3.0 or higher
  • Must be able to work full-time during the duration of the internship program
  • Experience Qualifications:
  • Class work in molecular biology, genetics, cell biology.
  • An understanding of molecular cloning techniques and/or mammalian cell culture
  • The ability to work successfully both independently and in a collaborative environment.
  • Ability to define problems, collect and analyze data, establish facts, and draw valid conclusions.
  • Ability to handle multiple tasks, manages time well and will put in extended time as needed.
  • Strong oral and written communication skills in English.
  • Flexibility to perform the small tasks as well as the big tasks while working in a rapidly developing environment.

Responsibilities

  • Participate in all the projects related to the development, optimization and manufacture of our proprietary gene editing tools.
  • Design and construct DNA vectors to be used in proprietary transposon technology and other gene editing platforms.
  • Perform basic mammalian cell culture techniques to assay and screen newly designed proteins and gene editing enzymes
image

Bio-Techne

Science & Healthcare
Industry
1001-5000
Employees

Mission & Purpose

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx®Prostate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.